Discovery of Non-Invasive Biomarkers for the Diagnosis of Endometriosis

Total Page:16

File Type:pdf, Size:1020Kb

Discovery of Non-Invasive Biomarkers for the Diagnosis of Endometriosis Irungu et al. Clin Proteom (2019) 16:14 https://doi.org/10.1186/s12014-019-9235-3 Clinical Proteomics RESEARCH Open Access Discovery of non-invasive biomarkers for the diagnosis of endometriosis Stella Irungu1, Dimitrios Mavrelos2, Jenny Worthington1, Oleg Blyuss1, Ertan Saridogan2 and John F. Timms1* Abstract Background: Endometriosis is a common gynaecological disorder afecting 5–10% of women of reproductive age who often experience chronic pelvic pain and infertility. Defnitive diagnosis is through laparoscopy, exposing patients to potentially serious complications, and is often delayed. Non-invasive biomarkers are urgently required to accelerate diagnosis and for triaging potential patients for surgery. Methods: This retrospective case control biomarker discovery and validation study used quantitative 2D-diference gel electrophoresis and tandem mass tagging–liquid chromatography–tandem mass spectrometry for protein expression profling of eutopic and ectopic endometrial tissue samples collected from 28 cases of endometriosis and 18 control patients undergoing surgery for investigation of chronic pelvic pain without endometriosis or prophylactic surgery. Samples were further sub-grouped by menstrual cycle phase. Selected diferentially expressed candidate markers (LUM, CPM, TNC, TPM2 and PAEP) were verifed by ELISA in a set of 87 serum samples collected from the same and additional women. Previously reported biomarkers (CA125, sICAM1, FST, VEGF, MCP1, MIF and IL1R2) were also validated and diagnostic performance of markers and combinations established. Results: Cycle phase and endometriosis-associated proteomic changes were identifed in eutopic tissue from over 1400 identifed gene products, yielding potential biomarker candidates. Bioinformatics analysis revealed enrichment of adhesion/extracellular matrix proteins and progesterone signalling. The best single marker for discriminating endo- metriosis from controls remained CA125 (AUC 0.63), with the best cross-validated multimarker models improving the AUC to 0.71–0.81, depending upon menstrual= cycle phase and control group. Conclusions: We have identifed menstrual cycle- and endometriosis-associated protein changes linked to various cellular processes that are potential biomarkers and that provide insight into the biology of endometriosis. Our data indicate that the markers tested, whilst not useful alone, have improved diagnostic accuracy when used in combina- tion and demonstrate menstrual cycle specifcity. Tissue heterogeneity and blood contamination is likely to have hindered biomarker discovery, whilst a small sample size precludes accurate determination of performance by cycle phase. Independent validation of these biomarker panels in a larger cohort is however warranted, and if successful, they may have clinical utility in triaging patients for surgery. Keywords: Endometriosis, Biomarkers, Eutopic tissue, Ectopic tissue, Serum *Correspondence: [email protected] 1 Department of Women’s Cancer, Institute for Women’s Health, University College London, Cruciform Building 1.1, Gower Street, London WC1E 6BT, UK Full list of author information is available at the end of the article © The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/ publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Irungu et al. Clin Proteom (2019) 16:14 Page 2 of 16 Introduction additionally validate biomarkers reported in the litera- Endometriosis is estimated to afect 5–10% of women ture [4]. of reproductive age. Although some women with endo- metriosis may be asymptomatic, it can cause signif- Materials and methods cant pain symptoms and infertility. Te diagnosis of Patient recruitment endometriosis can be difcult to achieve. Various stud- Patients and samples were sourced from the Univer- ies worldwide have documented a delay of 7–11 years sity College London Hospital Gynaecology Depart- from appearance of symptoms until diagnosis [1–3]. ment following ethical approval and informed consent. Tis delay is partly due to the fact that an invasive lap- Patients were those referred by their general practition- aroscopy is needed to establish the diagnosis in some ers or other clinicians for investigation of pelvic pain or women. Imaging techniques are sensitive for diagnosis for diagnosis and/or treatment of endometriosis. Tose of ovarian endometriomas and deep endometriosis in who agreed to undergo laparoscopic surgery for inves- experienced hands, but are less accurate for diagnosing tigation and treatment of endometriosis, pelvic pain or other forms of endometriosis [4]. bilateral salpingoophorectomy for strong family his- While eforts have been made to develop blood- tory of breast and ovarian cancer were approached and based diagnostic tests for endometriosis, few reported recruited. Inclusion criteria were as follows: ‘endome- markers have been independently validated and none triosis cases’ were defned as women diagnosed with are in clinical use. As a result, defnitive diagnosis of endometriosis at laparoscopy and confrmed histologi- endometriosis remains surgical, requiring laparoscopy cally; ‘controls with pain’ were defned as symptomatic under general anaesthetic, exposing patients to poten- women with pelvic pain of unknown cause or chronic tially serious complications. Difculty in establishing a pelvic infammatory disease without surgical evidence diagnosis leads to patients spending years on visits to of endometriosis; ‘controls without pain’ were regularly their doctors and unnecessary investigations, adding cycling women with no known disease undergoing bilat- to the signifcant economic burden of the disease [5]. eral tubal ligation and/or prophylactic bilateral salpin- While early stage endometriosis is not without conse- goophorectomy due to familial risk of breast and ovarian quence, delay in diagnosis may allow disease progres- cancer and with no visual evidence of endometriosis at sion with reduced treatment efciency and poorer laparoscopy. Te following women were excluded from outcomes. Tere is clearly an urgent and unmet need the study; post-menopausal women, women with a posi- for a minimally invasive diagnostic test for endometrio- tive pregnancy test or unknown pregnancy status on day sis, though clinically useful blood-borne markers have of surgery, those with other benign conditions or malig- yet to be found [6, 7]. Te aim of a non-invasive test nancies (particularly patients with fbroids and/or cancer of endometriosis should be to expedite clinical diagno- were excluded as these conditions may compromise the sis by achieving a high positive predictive value (> 90%) integrity of the endometrium), women on any hormonal or to triage patients for laparoscopic investigation for medication < 3 months prior to surgery and those whose conclusive pathological diagnosis. A lower sensitiv- surgical fndings and pathological reports were inconsist- ity may be tolerated for the latter if specifcity is high ent. Cycle phase was determined by a triple approach to (> 90%). Ideally, a test would also need to function ensure accuracy; chronologically, by histological dating independently of menstrual cycle phase. Early diagno- and by sex steroid hormone determination. Women with sis of endometriosis may allow preventative measures unconfrmed menstrual cycle stage were excluded. Addi- that delay progression of the disease such as use of the tional patient data was collected including age, fertility progesterone only pill or Mirena coil. Women hop- history, treatment history (oral contraceptive and GnRH ing to conceive or those who are refractory to medical analogue use), menstrual cycle phase, pain history, histo- management can be put forward for surgical treatment pathology fndings and anatomic characteristics of dis- earlier. ease lesions. All patient records were handled per NHS Te frst aim of our study was to identify potential confdentiality practices. Samples were anonymised and biomarkers through proteomic profling of eutopic sequentially numbered. A lab coding system and data- and ectopic endometrial tissue specimens taken from base were developed for recording anonymised patient women with a confrmed diagnosis of endometriosis and sample information. and relevant controls undergoing exploratory surgery for chronic pelvic pain without endometriosis or pro- Sample collection phylactic surgery due to strong familial risk of cancer. Endometrial tissue biopsies (eutopic endometrium) were Te second aim was to test these potential biomarkers obtained by Pipelle cannula or curettage from women in sera from a larger case control set of women, and undergoing laparoscopy. Ectopic endometrial tissue Irungu et al. Clin Proteom (2019) 16:14 Page 3 of 16 (endometriosis) samples were obtained from the same Ground tissue was lysed in 2D lysis bufer (8 M urea, 4% women at laparoscopy. Superfcial lesions and deep infl- w/v CHAPS and 10 mM Tris–HCl pH 8.3) using a ratio trating endometriosis samples only were used in this of 5 μL of lysis bufer per 1 mg of tissue at room tem- study, the rationale being
Recommended publications
  • Mechanical Forces Induce an Asthma Gene Signature in Healthy Airway Epithelial Cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T
    www.nature.com/scientificreports OPEN Mechanical forces induce an asthma gene signature in healthy airway epithelial cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T. Kho4, Kelan Tantisira1, Marc Santolini 1,5, Feixiong Cheng6,7,8, Jennifer A. Mitchel3, Maureen McGill3, Michael J. O’Sullivan3, Margherita De Marzio1,3, Amitabh Sharma1, Scott H. Randell9, Jefrey M. Drazen3, Jefrey J. Fredberg3 & Scott T. Weiss1,3* Bronchospasm compresses the bronchial epithelium, and this compressive stress has been implicated in asthma pathogenesis. However, the molecular mechanisms by which this compressive stress alters pathways relevant to disease are not well understood. Using air-liquid interface cultures of primary human bronchial epithelial cells derived from non-asthmatic donors and asthmatic donors, we applied a compressive stress and then used a network approach to map resulting changes in the molecular interactome. In cells from non-asthmatic donors, compression by itself was sufcient to induce infammatory, late repair, and fbrotic pathways. Remarkably, this molecular profle of non-asthmatic cells after compression recapitulated the profle of asthmatic cells before compression. Together, these results show that even in the absence of any infammatory stimulus, mechanical compression alone is sufcient to induce an asthma-like molecular signature. Bronchial epithelial cells (BECs) form a physical barrier that protects pulmonary airways from inhaled irritants and invading pathogens1,2. Moreover, environmental stimuli such as allergens, pollutants and viruses can induce constriction of the airways3 and thereby expose the bronchial epithelium to compressive mechanical stress. In BECs, this compressive stress induces structural, biophysical, as well as molecular changes4,5, that interact with nearby mesenchyme6 to cause epithelial layer unjamming1, shedding of soluble factors, production of matrix proteins, and activation matrix modifying enzymes, which then act to coordinate infammatory and remodeling processes4,7–10.
    [Show full text]
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
    [Show full text]
  • Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated with Downregulation of LMOD1, SYNPO2, PDLIM7, PLN and SYNM
    Markers of smooth muscle cells Perisic et al. Phenotypic modulation of smooth muscle cells in atherosclerosis is associated with downregulation of LMOD1, SYNPO2, PDLIM7, PLN and SYNM Perisic L1, Rykaczewska U1, Razuvaev A1, Sabater-Lleal M2, Lengquist M1, Miller CL3, Ericsson I1, Röhl S1, Kronqvist M1, Aldi S1, Magné J2, Vesterlund M4, Li Y2, Yin H2, Gonzalez Diez M2, Roy J1, Baldassarre D5,6, Veglia F6, Humphries SE7, de Faire U8,9, Tremoli E5,6, on behalf of the IMPROVE study group, Odeberg J10, Vukojević V11, Lehtiö J4, Maegdefessel L2, Ehrenborg E2, Paulsson-Berne G2, Hansson GK2, Lindeman JHN12, Eriksson P2, Quertermous T3, Hamsten A2, Hedin U1 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Sweden, 2Department of Medicine, Karolinska Institutet, Sweden, 3Division of Vascular Surgery, Stanford University, USA, 4Science for Life Laboratory, Sweden, 5Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy, 6Centro Cardiologico Monzino, IRCCS, Milan, Italy, 7British Heart Foundation Laboratories, University College of London, Department of Medicine, Rayne Building, London, United Kingdom, 8Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, 9Department of Cardiology, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden, 10Science for Life Laboratory, Department of Proteomics, Sweden, 11Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Sweden, 12Department of Vascular
    [Show full text]
  • Original Article Prognostic Value of the PDLIM Family in Acute Myeloid Leukemia
    Am J Transl Res 2019;11(9):6124-6131 www.ajtr.org /ISSN:1943-8141/AJTR0096980 Original Article Prognostic value of the PDLIM family in acute myeloid leukemia Longzhen Cui1,2,3,4*, Zhiheng Cheng5*, Kai Hu6*, Yifan Pang7, Yan Liu3, Tingting Qian1,2, Liang Quan1,2, Yifeng Dai8, Ying Pang1, Xu Ye1, Jinlong Shi9, Lin Fu1,2,4 1Department of Hematology, 2Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, Guangdong, China; 3Translational Medicine Center, 4Department of Hematology, Huaihe Hospital of Henan University, Kaifeng 475000, Henan, China; 5Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; 6Department of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China; 7Department of Medicine, William Beaumont Hospital, Royal Oak, MI 48073, USA; 8Immunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; 9Department of Medical Big Data, Chinese PLA General Hospital, Beijing 100853, China. *Equal contributors. Received April 22, 2019; Accepted June 26, 2019; Epub September 15, 2019; Published September 30, 2019 Abstract: Acute myeloid leukemia (AML) is a genetically complex, highly aggressive hematological malignancy. Prognosis is usually with grim. PDZ and LIM domain proteins (PDLIM) are involved in the regulation of a variety of biological processes, including cytoskeletal organization, cell differentiation, organ development, neural signaling or tumorigenesis. The clinical and prognostic value of the PDLIM family in AML is unclear. To understand the role of PDLIM expression in AML, The Cancer Genome Atlas (TCGA) database was screened and 155 de novo AML pa- tients with complete clinical information and the expression data of the PDLIM family were included in the study.
    [Show full text]
  • PDLIM7 (NM 005451) Human Untagged Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for SC111943 PDLIM7 (NM_005451) Human Untagged Clone Product data: Product Type: Expression Plasmids Product Name: PDLIM7 (NM_005451) Human Untagged Clone Tag: Tag Free Symbol: PDLIM7 Synonyms: LMP1; LMP3 Vector: pCMV6-XL4 E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: None Fully Sequenced ORF: >NCBI ORF sequence for NM_005451, the custom clone sequence may differ by one or more nucleotides ATGGATTCCTTCAAAGTAGTGCTGGAGGGGCCAGCACCTTGGGGCTTCCGGCTGCAAGGGGGCAAGGACT TCAATGTGCCCCTCTCCATTTCCCGGCTCACTCCTGGGGGCAAAGCGGCGCAGGCCGGAGTGGCCGTGGG TGACTGGGTGCTGAGCATCGATGGCGAGAATGCGGGTAGCCTCACACACATCGAAGCTCAGAACAAGATC CGGGCCTGCGGGGAGCGCCTCAGCCTGGGCCTCAGCAGGGCCCAGCCGGTTCAGAGCAAACCGCAGAAGG CCTCCGCCCCCGCCGCGGACCCTCCGCGGTACACCTTTGCACCCAGCGTCTCCCTCAACAAGACGGCCCG GCCCTTTGGGGCGCCCCCGCCCGCTGACAGCGCCCCGCAGCAGAATGGACAGCCGCTCCGACCGCTGGTC CCAGATGCCAGCAAGCAGCGGCTGATGGAGAACACAGAGGACTGGCGGCCGCGGCCGGGGACAGGCCAGT CGCGTTCCTTCCGCATCCTTGCCCACCTCACAGGCACCGAGTTCATGCAAGACCCGGATGAGGAGCACCT GAAGAAATCAAGCCAGGTGCCCAGGACAGAAGCCCCAGCCCCAGCCTCATCTACACCCCAGGAGCCCTGG CCTGGCCCTACCGCCCCCAGCCCTACCAGCCGCCCGCCCTGGGCTGTGGACCCTGCGTTTGCCGAGCGCT ATGCCCCGGACAAAACGAGCACAGTGCTGACCCGGCACAGCCAGCCGGCCACGCCCACGCCGCTGCAGAG CCGCACCTCCATTGTGCAGGCAGCTGCCGGAGGGGTGCCAGGAGGGGGCAGCAACAACGGCAAGACTCCC GTGTGTCACCAGTGCCACAAGGTCATCCGGGGCCGCTACCTGGTGGCGCTGGGCCACGCGTACCACCCGG AGGAGTTTGTGTGTAGCCAGTGTGGGAAGGTCCTGGAAGAGGGTGGCTTCTTTGAGGAGAAGGGCGCCAT
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • Meta-Analysis of Genomewide Association Studies Reveals Genetic Variants for Hip Bone Geometry
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author J Bone Miner Manuscript Author Res. Author Manuscript Author manuscript; available in PMC 2019 July 23. Published in final edited form as: J Bone Miner Res. 2019 July ; 34(7): 1284–1296. doi:10.1002/jbmr.3698. Meta-Analysis of Genomewide Association Studies Reveals Genetic Variants for Hip Bone Geometry A full list of authors and affiliations appears at the end of the article. Abstract Hip geometry is an important predictor of fracture. We performed a meta-analysis of GWAS studies in adults to identify genetic variants that are associated with proximal femur geometry phenotypes. We analyzed four phenotypes: (i) femoral neck length; (ii) neck-shaft angle; (iii) femoral neck width, and (iv) femoral neck section modulus, estimated from DXA scans using algorithms of hip structure analysis. In the Discovery stage, 10 cohort studies were included in the fixed-effect meta-analysis, with up to 18,719 men and women ages 16 to 93 years. Association analyses were performed with ~2.5 million polymorphisms under an additive model adjusted for age, body mass index, and height. Replication analyses of meta-GWAS significant loci (at adjusted genomewide significance [GWS], threshold p ≤ 2.6 × 10−8) were performed in seven additional cohorts in silico. We looked up SNPs associated in our analysis, for association with height, bone mineral density (BMD), and fracture. In meta-analysis (combined Discovery and Replication stages), GWS associations were found at 5p15 (IRX1 and ADAMTS16); 5q35 near FGFR4; at 12p11 (in CCDC91); 11q13 (near LRP5 and PPP6R3 (rs7102273)). Several hip geometry signals overlapped with BMD, including LRP5 (chr.
    [Show full text]
  • The Human Gene Connectome As a Map of Short Cuts for Morbid Allele Discovery
    The human gene connectome as a map of short cuts for morbid allele discovery Yuval Itana,1, Shen-Ying Zhanga,b, Guillaume Vogta,b, Avinash Abhyankara, Melina Hermana, Patrick Nitschkec, Dror Friedd, Lluis Quintana-Murcie, Laurent Abela,b, and Jean-Laurent Casanovaa,b,f aSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; bLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Paris Descartes University, Institut National de la Santé et de la Recherche Médicale U980, Necker Medical School, 75015 Paris, France; cPlateforme Bioinformatique, Université Paris Descartes, 75116 Paris, France; dDepartment of Computer Science, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel; eUnit of Human Evolutionary Genetics, Centre National de la Recherche Scientifique, Unité de Recherche Associée 3012, Institut Pasteur, F-75015 Paris, France; and fPediatric Immunology-Hematology Unit, Necker Hospital for Sick Children, 75015 Paris, France Edited* by Bruce Beutler, University of Texas Southwestern Medical Center, Dallas, TX, and approved February 15, 2013 (received for review October 19, 2012) High-throughput genomic data reveal thousands of gene variants to detect a single mutated gene, with the other polymorphic genes per patient, and it is often difficult to determine which of these being of less interest. This goes some way to explaining why, variants underlies disease in a given individual. However, at the despite the abundance of NGS data, the discovery of disease- population level, there may be some degree of phenotypic homo- causing alleles from such data remains somewhat limited. geneity, with alterations of specific physiological pathways under- We developed the human gene connectome (HGC) to over- come this problem.
    [Show full text]
  • A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family
    Rockefeller University Digital Commons @ RU Student Theses and Dissertations 2018 A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family Linda Molla Follow this and additional works at: https://digitalcommons.rockefeller.edu/ student_theses_and_dissertations Part of the Life Sciences Commons A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY A Thesis Presented to the Faculty of The Rockefeller University in Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy by Linda Molla June 2018 © Copyright by Linda Molla 2018 A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY Linda Molla, Ph.D. The Rockefeller University 2018 APOBEC2 is a member of the AID/APOBEC cytidine deaminase family of proteins. Unlike most of AID/APOBEC, however, APOBEC2’s function remains elusive. Previous research has implicated APOBEC2 in diverse organisms and cellular processes such as muscle biology (in Mus musculus), regeneration (in Danio rerio), and development (in Xenopus laevis). APOBEC2 has also been implicated in cancer. However the enzymatic activity, substrate or physiological target(s) of APOBEC2 are unknown. For this thesis, I have combined Next Generation Sequencing (NGS) techniques with state-of-the-art molecular biology to determine the physiological targets of APOBEC2. Using a cell culture muscle differentiation system, and RNA sequencing (RNA-Seq) by polyA capture, I demonstrated that unlike the AID/APOBEC family member APOBEC1, APOBEC2 is not an RNA editor. Using the same system combined with enhanced Reduced Representation Bisulfite Sequencing (eRRBS) analyses I showed that, unlike the AID/APOBEC family member AID, APOBEC2 does not act as a 5-methyl-C deaminase.
    [Show full text]
  • Enigma Proteins Regulate YAP Mechanotransduction Ahmed Elbediwy1,*, Hannah Vanyai1, Maria-Del-Carmen Diaz-De-La-Loza1, David Frith2, Ambrosius P
    © 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs221788. doi:10.1242/jcs.221788 SHORT REPORT Enigma proteins regulate YAP mechanotransduction Ahmed Elbediwy1,*, Hannah Vanyai1, Maria-del-Carmen Diaz-de-la-Loza1, David Frith2, Ambrosius P. Snijders2 and Barry J. Thompson1,* ABSTRACT adhesome containing a large number of proteins that are likely to be Human cells can sense mechanical stress acting upon integrin involved in either adhesion or mechanotransduction (Horton adhesions and respond by sending the YAP (also known as YAP1) et al., 2015). and TAZ (also known as WWTR1) transcriptional co-activators to One crucial downstream effector of integrin signaling is the the nucleus to drive TEAD-dependent transcription of target genes. Yes-associated protein (YAP, also known as YAP1), originally How integrin signaling activates YAP remains unclear. Here, we show discovered by virtue of its ability to form a complex with the Src that integrin-mediated mechanotransduction requires the Enigma family kinase, Yes (Sudol, 1994). YAP (and its paralog TAZ, also and Enigma-like proteins (PDLIM7 and PDLIM5, respectively; known as WWTR1) was found to be a transcriptional co-activator denoted for the family of PDZ and LIM domain-containing proteins). that is negatively regulated by interaction with 14-3-3 proteins (after YAP binds to PDLIM5 and PDLIM7 (hereafter PDLIM5/7) via its serine phosphorylation) and positively regulated by interaction with C-terminal PDZ-binding motif (PBM), which is essential for full PDZ domains (via a C-terminal PDZ-binding motif or PBM) (Kanai nuclear localization and activity of YAP. Accordingly, silencing of et al., 2000; Yagi et al., 1999).
    [Show full text]
  • Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated with Downregulation of LMOD1, SYNPO2, PDLIM7, PLN and SYNM
    Markers of smooth muscle cells Perisic et al. Phenotypic modulation of smooth muscle cells in atherosclerosis is associated with downregulation of LMOD1, SYNPO2, PDLIM7, PLN and SYNM Matic Perisic L1, Rykaczewska U1, Razuvaev A1, Sabater-Lleal M2, Lengquist M1, Miller CL3, Ericsson I1, Röhl S1, Kronqvist M1, Aldi S1, Magné J2, Paloschi V2, Vesterlund M4, Li Y2, Jin H2, Gonzalez Diez M2, Roy J1, Baldassarre D5,6, Veglia F6, Humphries SE7, de Faire U8,9, Tremoli E5,6, on behalf of the IMPROVE study group, Odeberg J10, Vukojević V11, Lehtiö J4, Maegdefessel L2, Ehrenborg E2, Paulsson- Berne G2, Hansson GK2, Lindeman JHN12, Eriksson P2, Quertermous T3, Hamsten A2, Hedin U1 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Sweden, 2Department of Medicine, Karolinska Institutet, Sweden, 3Division of Vascular Surgery, Stanford University, USA, 4Science for Life Laboratory, Sweden, 5Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy, 6Centro Cardiologico Monzino, IRCCS, Milan, Italy, 7British Heart Foundation Laboratories, University College of London, Department of Medicine, Rayne Building, London, United Kingdom, 8Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, 9Department of Cardiology, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden, 10Science for Life Laboratory, Department of Proteomics, Sweden, 11Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Sweden,
    [Show full text]
  • The Human Gene Connectome As a Map of Short Cuts for Morbid Allele Discovery
    The human gene connectome as a map of short cuts for morbid allele discovery Yuval Itana,1, Shen-Ying Zhanga,b, Guillaume Vogta,b, Avinash Abhyankara, Melina Hermana, Patrick Nitschkec, Dror Friedd, Lluis Quintana-Murcie, Laurent Abela,b, and Jean-Laurent Casanovaa,b,f aSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; bLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Paris Descartes University, Institut National de la Santé et de la Recherche Médicale U980, Necker Medical School, 75015 Paris, France; cPlateforme Bioinformatique, Université Paris Descartes, 75116 Paris, France; dDepartment of Computer Science, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel; eUnit of Human Evolutionary Genetics, Centre National de la Recherche Scientifique, Unité de Recherche Associée 3012, Institut Pasteur, F-75015 Paris, France; and fPediatric Immunology-Hematology Unit, Necker Hospital for Sick Children, 75015 Paris, France Edited* by Bruce Beutler, University of Texas Southwestern Medical Center, Dallas, TX, and approved February 15, 2013 (received for review October 19, 2012) High-throughput genomic data reveal thousands of gene variants to detect a single mutated gene, with the other polymorphic genes per patient, and it is often difficult to determine which of these being of less interest. This goes some way to explaining why, variants underlies disease in a given individual. However, at the despite the abundance of NGS data, the discovery of disease- population level, there may be some degree of phenotypic homo- causing alleles from such data remains somewhat limited. geneity, with alterations of specific physiological pathways under- We developed the human gene connectome (HGC) to over- come this problem.
    [Show full text]